Surface Logix

Surface Logix is a drug development company using its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.  By using its proprietary chemistry platform — the Pharmacomer™ Technology Platform –Surface Logix creates New Chemical Entities that respond dynamically to the various physiological microenvironments in the human body.  By enhancing molecular functionality, Surface Logix is able to solve PK and PD problems not addressable with traditional medicinal chemistry practices.